Early treatment with disease modifying therapies (DMTs) is most effective in preventing progression of multiple sclerosis, according to a large-scale Danish study. The study “Early versus Later Treatment Start in Multiple Sclerosis – A Register Based Cohort Study” is to be presented at the 2018 Annual Meeting of the American Academy of Neurology (AAN). This … Continue reading Early treatment does delay MS disease progression, new study confirms
Many people with multiple sclerosis await the launch of each new disease modifying therapy (DMT), hoping it will bring some improvement. Meanwhile, a significant number of those in the same situation seem to ignore a new drug and carry on regardless. But why? Well, there are a number of reasons; let’s take a look at a … Continue reading Why are DMTs – Drugs to treat MS – Resisted by so Many?